Erasca (ERAS) Adds 13%; Soars 310% YTD [Yahoo! Finance]
Erasca, Inc. (ERAS)
Company Research
Source: Yahoo! Finance
Erasca rallied for a second day on Thursday, jumping 13.04 percent to close at $15.26 apiece on strong investor optimism, backed by earlier optimistic coverage from several analysts. Year-to-date, the company has already seen its stock price soar by 310 percent, making it one of the top-performing stocks this year. Investors are also positioning portfolios ahead of initial data from clinical trials to test the efficacy of its treatment candidate, ERAS-0015, in patients with RAS-mutant solid tumors in the US and China. Erasca (ERAS) Adds 13%; Soars 310% YTD Photo by RDNE on Pexels In January this year, ERAS-0015 showed early promising results in one of Erasca Inc.'s (NASDAQ:ERAS) clinical studies, particularly during dose escalations. According to the company, it saw two confirmed partial responses and one unconfirmed partial response during the clinical study of its pan-RAS molecular glue degrader ERAS-0015. In addition, more unconfirmed responses were observed in patie
Show less
Read more
Impact Snapshot
Event Time:
ERAS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ERAS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ERAS alerts
High impacting Erasca, Inc. news events
Weekly update
A roundup of the hottest topics
ERAS
News
- Erasca (ERAS) had its price target raised by JPMorgan Chase & Co. from $24.00 to $25.00. They now have an "overweight" rating on the stock.MarketBeat
- Erasca (ERAS) had its price target raised by Guggenheim from $12.00 to $20.00. They now have a "buy" rating on the stock.MarketBeat
- Erasca (ERAS) had its price target raised by Piper Sandler from $11.00 to $18.00. They now have an "overweight" rating on the stock.MarketBeat
- Erasca GAAP EPS of -$0.19 [Seeking Alpha]Seeking Alpha
- Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial ResultsGlobeNewswire
ERAS
Earnings
- 11/12/25 - In-Line
ERAS
Sec Filings
- 3/16/26 - Form 144
- 3/12/26 - Form 10-K
- 3/12/26 - Form 8-K
- ERAS's page on the SEC website